Unique Case of Pseudoprogression Manifesting as Lung Cavitation After Pembrolizumab Treatment

J Thorac Oncol. 2019 May;14(5):e108-e109. doi: 10.1016/j.jtho.2018.12.024.

Authors

Kentaro Masuhiro¹, Takayuki Shiroyama², Izumi Nagatomo¹, Atsushi Kumanogoh¹

Affiliations

¹ Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
² Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: takayuki.s12@hotmail.co.jp.

PMID: 31027746
DOI: 10.1016/j.jtho.2018.12.024

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / pharmacology
Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use*
Disease Progression
Humans
Lung Neoplasms / drug therapy*
Male

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab